Key result
CEPD experience in carotid stenting may reduce cerebral complication risks during TAVI.
Lessons learned from 10 years of cerebral embolic protection in carotid artery stenting may help optimize device design and reduce stroke risk in TAVI.
Answers are grounded in this paper and cite their sources.
CEPD experience in carotid stenting does not translate; leaves open efficacy and safety in TAVR and other structural procedures.
In the last 30 years, development of minimally invasive percutaneous procedures to treat cardiovascular defects has been thriving. Although these techniques present obvious advantages, like avoiding cardiopulmonary bypass, the passage of catheter systems and the deployment of devices in the blood circulation can cause particle embolization that may result in stroke. In carotid artery stenting, cerebral embolic protection devices (CEPD) such as filtering membranes have been available for already 10 years. In transcatheter aortic valve implantation (TAVI), the development of CEPD is starting and three membrane-based devices are in clinical trials. There are controversial discussions about the efficacy of CEPD in TAVI. The experience with CEPD in carotid artery stenting can help to understand some of the technical issues and shortcomings of current devices and thereby ultimately reduce cerebral complication risks during TAVI procedures.
No takes yet. Share an insight, caveat, or question.
Egron et al. (2015) conducted a review in Transcatheter aortic valve implantation (TAVI) and carotid artery stenting. Cerebral embolic protection devices (CEPD) was evaluated. Experience with cerebral embolic protection devices in carotid artery stenting can help understand technical issues and reduce cerebral complication risks during transcatheter aortic valve implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: